Croix-Rousse University Hospital
Lyon, 69004, France
NCT Number: NCT03206268
The aim of this study is to evaluate the correlation of retinal nerve fiber layer (RNFL) thickness measured using spectral domain optical coherence tomography (SD-OCT) and scanning laser polarimetry (SLP) in uveitic eyes compared to healthy eyes.
A descriptive, observational, prospective, consecutive, cross-sectional, controlled, mono-center case series was conducted from May to October 2015. Clinical characteristics, best-corrected visual acuity, intra-ocular pressure, RNFL thickness measurement with SD-OCT and SLP using GDx variable corneal compensation (GDx VCC) were performed for each patient. An evaluation of anterior chamber inflammation with laser flare cell meter was also carried out. Correlations between SD-OCT and GDx VCC RNFL measurement were evaluated by linear regression analysis.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Lyon, 69004, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
RNFL thickness measurements obtained using SD-OCT and SLP using GDx variable corneal compensation
Time frame: at inclusion
measures are made with spectral domain optical coherence tomography (SD-OCT) in micrometer
Time frame: at inclusion
measures are made with scanning laser polarimetry (SLP) in micrometer
Hospices Civils de Lyon
Other
Correlation in Retinal Nerve Fiber Layer Thickness in Uveitis and Healthy Eyes Using Scanning Laser Polarimetry and Optical Coherence Tomography
Acronym: Real
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01859299
Eye Diseases, Uveal Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT05286203
Communicable Diseases, Disease Attributes
San Francisco, California, United States
View Trial DetailsNCT02656381
Behcet Syndrome, Cardiovascular Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT04340505
Eye Diseases, Uveal Diseases
Cleveland, Ohio, United States
View Trial Details